The Birth of Naloxone: An Intellectual History of an Ambivalent Opioid

Naloxone, which reverses the effects of opioids, was synthesized in 1960, though the hunt for opioid antagonists began a half-century earlier. The history of this quest reveals how cultural and medical attitudes toward opioids have been marked by a polarization of discourse that belies a keen ambiva...

Full description

Saved in:  
Bibliographic Details
Authors: Kolbe, Laura (Author) ; Fins, Joseph J. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Cambridge Univ. Press 2021
In: Cambridge quarterly of healthcare ethics
Year: 2021, Volume: 30, Issue: 4, Pages: 637-650
Further subjects:B War on drugs
B History of Medicine
B FDA
B Naloxone
B Addiction
B Opioids
B Palliative Care
B Neuroethics
B Medical Research
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)
Description
Summary:Naloxone, which reverses the effects of opioids, was synthesized in 1960, though the hunt for opioid antagonists began a half-century earlier. The history of this quest reveals how cultural and medical attitudes toward opioids have been marked by a polarization of discourse that belies a keen ambivalence. From 1915 to 1960, researchers were stymied in seeking a “pure” antidote to opioids, discovering instead numerous opioid molecules of mixed or paradoxical properties. At the same time, the quest for a dominant explanatory and therapeutic model for addiction was likewise unsettled. After naloxone’s discovery, new dichotomizing language arose in the “War on Drugs,” in increasingly divergent views between addiction medicine and palliative care, and in public debates about layperson naloxone access. Naloxone, one of the emblematic drugs of our time, highlights the ambivalence latent in public and biomedical discussions of opioids as agents of risk and relief.
ISSN:1469-2147
Contains:Enthalten in: Cambridge quarterly of healthcare ethics
Persistent identifiers:DOI: 10.1017/S0963180121000116